The Online Investor
Evofem Biosciences Inc (EVFM)

Evofem Biosciences is a commercial-stage biopharmaceutical company committed to developing and commercializing products to address unmet needs in women's sexual and reproductive health, including woman-controlled contraception and protection from certain sexually transmitted infections. Co.'s commercial product, Phexxi, is the U.S. Food and Drug Administration (FDA)-approved, hormone-free, woman-controlled, prescription contraceptive gel for women. Co. is evaluating Phexxi for two potential new indications: the prevention of chlamydia and the prevention of gonorrhea in women. The FDA has designated Phexxi, using the investigational name EVO100, as a Qualified Infectious Disease Product.
Company Name: 
Evofem Biosciences Inc
Website: 
www.evofem.com
Sector: 
Drugs & Pharmaceuticals
Number of ETFs Holding EVFM: 
3
Total Market Value Held by ETFs: 
$458594
Total Market Capitalization: 
$12.00M
% of Market Cap. Held by ETFs: 
3.82%
Quotes delayed 20 minutes

Email EnvelopeFree EVFM Email Alerts:
Get SEC Filing Alerts
Get Dividend Alerts

Buy (3.17 out of 4)
26th percentile
(ranked lower than approx. 74% of all stocks covered)

Analysts' Target Price:
EVFM Stock Forecast

Based on Zacks ABR data;
powered by Xignite

Evofem Biosciences Inc (EVFM) Page | The Online Investor Page | www.TheOnlineInvestor.com

Copyright © 1998 - 2022, All Rights Reserved
Nothing in The Online Investor is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and stock market videos powered by Market News Video. Quote data delayed at least 20 minutes; data powered by Ticker Technologies, and Mergent. Contact The Online Investor; Meet Our Editorial Staff.